Definition
Osteopetrosis is a rare hereditary disorder characterized by abnormal bone densification resulting from impaired osteoclast-mediated bone resorption. The condition leads to the formation of overly dense but brittle bones.
Overview
The disease presents in two principal clinical forms:
- Autosomal recessive (malignant) osteopetrosis – often manifests in infancy or early childhood, progresses rapidly, and can be life‑threatening without treatment.
- Autosomal dominant (benign) osteopetrosis – typically identified in adolescence or adulthood, progresses more slowly, and may remain asymptomatic or cause mild skeletal abnormalities.
Incidence is estimated at 1 per 100,000 to 500,000 live births for the malignant form, with the benign form being less precisely quantified due to its milder phenotype. Diagnosis relies on radiographic evidence of generalized osteosclerosis, laboratory assessment of bone turnover markers, and genetic testing for mutations in genes such as TCIRG1, CLCN7, OSTM1, and CAII.
Clinical manifestations may include:
- Fractures despite increased bone density
- Cranial nerve compression leading to visual or auditory deficits
- Hematologic complications such as anemia, thrombocytopenia, and extramedullary hematopoiesis due to reduced marrow space
- Growth retardation and dental anomalies
Management strategies encompass supportive care, hematopoietic stem cell transplantation (particularly for the malignant form), and emerging therapies targeting osteoclast function (e.g., interferon‑γ, bone‑targeted enzymes). Orthopedic interventions address fractures and deformities.
Etymology/Origin
The term derives from Greek roots: osteo‑ meaning “bone” and ‑petros meaning “stone,” together conveying the notion of “stone‑like bone.”
Characteristics
| Feature | Details |
|---|---|
| Pathophysiology | Defective osteoclast differentiation or activity impairs bone resorption, causing accumulation of primary spongiosa and failure of normal bone remodeling. |
| Radiographic Findings | Diffuse, symmetrical osteosclerosis; “bone‑in‑bone” appearance; Erlenmeyer flask deformity of long‑bone metaphyses. |
| Laboratory Findings | Normal or low serum calcium, elevated alkaline phosphatase, variable levels of vitamin D metabolites. |
| Complications | Pathologic fractures, cranial nerve palsies, hypocalcemia, osteomyelitis of the jaw, severe anemia, and immune deficiency. |
| Therapeutic Options | Hematopoietic stem cell transplantation, interferon‑γ therapy, calcium and vitamin D supplementation, surgical correction of fractures, and experimental gene‑editing approaches. |
Related Topics
- Osteoclast – the bone‑resorbing cell type whose dysfunction underlies osteopetrosis.
- Bone remodeling – the physiological process disrupted in the disease.
- Pycnodysostosis – another bone‑sclerosis disorder caused by cathepsin K deficiency.
- Osteogenesis imperfecta – a contrasting condition of bone fragility due to collagen defects.
- Hematopoietic stem cell transplantation – a curative treatment option for severe forms.
- Genetic mutations (e.g., TCIRG1, CLCN7) – specific molecular defects associated with various osteopetrosis phenotypes.